Cargando…

The Fibrinogen-like Domain of ANGPTL3 Facilitates Lipolysis in 3T3-L1 Cells by Activating the Intracellular Erk Pathway

Background: ANGPTL3 stimulates lipolysis in adipocytes, but the underlying molecular mechanism is yet unknown. The C-terminal fibrinogen-like domain of ANGPTL3 (ANGPTL3-Fld) activates the AKT pathway in endothelial cells. Hence, we evaluated whether ANGPTL3-Fld stimulates lipolysis in adipocytes thr...

Descripción completa

Detalles Bibliográficos
Autores principales:	Bini, Simone, Pecce, Valeria, Di Costanzo, Alessia, Polito, Luca, Ghadiri, Ameneh, Minicocci, Ilenia, Tambaro, Federica, Covino, Stella, Arca, Marcello, D’Erasmo, Laura
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9028860/ https://www.ncbi.nlm.nih.gov/pubmed/35454174 http://dx.doi.org/10.3390/biom12040585

Ejemplares similares

The Interplay between Angiopoietin-Like Proteins and Adipose Tissue: Another Piece of the Relationship between Adiposopathy and Cardiometabolic Diseases?
por: Bini, Simone, et al.
Publicado: (2021)

Efficacy of Long-Term Treatment of Autosomal Recessive Hypercholesterolemia With Lomitapide: A Subanalysis of the Pan-European Lomitapide Study
por: D’Erasmo, Laura, et al.
Publicado: (2022)

Rare Treatments for Rare Dyslipidemias: New Perspectives in the Treatment of Homozygous Familial Hypercholesterolemia (HoFH) and Familial Chylomicronemia Syndrome (FCS)
por: D’Erasmo, Laura, et al.
Publicado: (2021)

Effectiveness of clinical scores in predicting coronary artery disease in familial hypercholesterolemia: a coronary computed tomography angiography study
por: Catapano, Federica, et al.
Publicado: (2023)

Clinical Implications of Monogenic Versus Polygenic Hypercholesterolemia: Long‐Term Response to Treatment, Coronary Atherosclerosis Burden, and Cardiovascular Events
por: D’Erasmo, Laura, et al.
Publicado: (2021)

Circulating Angptl3 and Angptl8 Are Increased in Patients with Hypothyroidism
por: Yang, Longyan, et al.
Publicado: (2019)

ANGPTL3 is a novel biomarker as it activates ERK/MAPK pathway in oral cancer
por: Koyama, Tomoyoshi, et al.
Publicado: (2015)

The adrenergic-induced ERK3 pathway drives lipolysis and suppresses energy dissipation
por: El-Merahbi, Rabih, et al.
Publicado: (2020)

ANGPTL3 as therapeutic target
por: Kersten, Sander
Publicado: (2021)

Genetic Mimicry Analysis Reveals the Specific Lipases Targeted by the ANGPTL3-ANGPTL8 Complex and ANGPTL4
por: Landfors, Fredrik, et al.
Publicado: (2022)

ANGPTL8 promotes the ability of ANGPTL3 to bind and inhibit lipoprotein lipase
por: Chi, Xun, et al.
Publicado: (2017)

Serum ANGPTL8 and ANGPTL3 as Predictors of Triglyceride Elevation in Adult Women
por: Stefanska, Anna, et al.
Publicado: (2022)

Nonalcoholic Fatty Liver Disease (NAFLD), But not Its Susceptibility Gene Variants, Influences the Decrease of Kidney Function in Overweight/Obese Children
por: Di Costanzo, Alessia, et al.
Publicado: (2019)

Structures of Angptl3 and Angptl4, modulators of triglyceride levels and coronary artery disease
por: Biterova, Ekaterina, et al.
Publicado: (2018)

Circulating ANGPTL3 and ANGPTL4 levels predict coronary artery atherosclerosis severity
por: Sun, Ting, et al.
Publicado: (2021)

The role of ANGPTL3 in controlling lipoprotein metabolism
por: Tikka, Anna, et al.
Publicado: (2016)

Evinacumab, an ANGPTL3 Inhibitor, in the Treatment of Dyslipidemia
por: Sosnowska, Bożena, et al.
Publicado: (2022)

Increased ANGPTL3, 4 and ANGPTL8/betatrophin expression levels in obesity and T2D
por: Abu-Farha, Mohamed, et al.
Publicado: (2016)

Differential Expression of the Host Lipid Regulators ANGPTL-3 and ANGPTL-4 in HCV Infection and Treatment
por: Valiakou, Vaia, et al.
Publicado: (2021)

Variable Changes of Circulating ANGPTL3 and ANGPTL4 in Different Obese Phenotypes: Relationship with Vasodilator Dysfunction
por: Schinzari, Francesca, et al.
Publicado: (2021)

Phosphorylation of Beta-3 adrenergic receptor at serine 247 by ERK MAP kinase drives lipolysis in obese adipocytes
por: Hong, Shangyu, et al.
Publicado: (2018)

The iPSC Awakens ANGPTL3 in Tangier Disease
por: Lee, Man K.S., et al.
Publicado: (2017)

ANGPTL3 as a Drug Target in Hyperlipidemia and Atherosclerosis
por: Mohamed, Farzahna, et al.
Publicado: (2022)

Angiopoietin-like protein 3 (ANGPTL3) deficiency and familial combined hypolipidemia
por: Tarugi, Patrizia, et al.
Publicado: (2019)

Angiopoietin-Like Protein 3 (ANGPTL3) Modulates Lipoprotein Metabolism and Dyslipidemia
por: Chen, Pei-Yi, et al.
Publicado: (2021)

Angiopoietin-Like Protein 3 (ANGPTL3) Inhibitors in the Management of Refractory Hypercholesterolemia
por: Kosmas, Constantine E, et al.
Publicado: (2022)

Long‐term hepatic safety of lomitapide in homozygous familial hypercholesterolaemia
por: Larrey, Dominique, et al.
Publicado: (2022)

Angiopoietin-like protein 8 differentially regulates ANGPTL3 and ANGPTL4 during postprandial partitioning of fatty acids
por: Chen, Yan Q., et al.
Publicado: (2020)

ANGPTL3 gene variants in subjects with familial combined hyperlipidemia
por: Bea, A. M., et al.
Publicado: (2021)

ANGPTL3 impacts proteinuria and hyperlipidemia in primary nephrotic syndrome
por: Zhong, Fu, et al.
Publicado: (2022)

ANGPTL3 Levels in Healthy and Mild Preeclamptic Pregnant Women
por: Garces, Maria F, et al.
Publicado: (2021)

Treatment of Homozygous Familial Hypercholesterolemia With ANGPTL3 Inhibitor, Evinacumab
por: Shamsudeen, Isabel, et al.
Publicado: (2023)

Effects of Chrysoeriol on Adipogenesis and Lipolysis in 3T3-L1 Adipocytes
por: Song, Jinhee, et al.
Publicado: (2022)

Effect of Crocetin on Basal Lipolysis in 3T3-L1 Adipocytes
por: Cimas, Francisco J., et al.
Publicado: (2023)

Angiopoietin-Like 3 (ANGPTL3) and Atherosclerosis: Lipid and Non-Lipid Related Effects
por: Lupo, Maria Giovanna, et al.
Publicado: (2018)

Effect of ANGPTL7 on Proliferation and Differentiation of MC3T3-E1 Cells
por: Lu, XiaoQing, et al.
Publicado: (2019)

Lipid-Lowering Therapy in Patients with Coronary Heart Disease and Prior Stroke: Mission Impossible?
por: Temporelli, Pier Luigi, et al.
Publicado: (2021)

Farrerol Induces Cancer Cell Death via ERK Activation in SKOV3 Cells and Attenuates TNF-α-Mediated Lipolysis
por: Chae, Jongbeom, et al.
Publicado: (2021)

Effects of Epigallocatechin-3-Gallate on Autophagic Lipolysis in Adipocytes
por: Kim, Sang-Nam, et al.
Publicado: (2017)

GALNT2 regulates ANGPTL3 cleavage in cells and in vivo of mice
por: Li, Xuedan, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_vkiju9e027vbcag1g8hmco7pmp